Authors
-
Julia Brasileiro de Faria Cavalcante
Department of Neurosurgery, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil
Author
-
Pedro Nogarotto Cembraneli
Department of Neurosurgery, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil
Author
-
Renata Brasileiro de Faria Cavalcante
Department of Neurosurgery, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil
Author
-
José Edison da Silva Cavalcante
Department of Neurosurgery, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil
Author
-
Alessandro Fonseca Cardoso
Department of Neurosurgery, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil
Author
-
Chrystiano Fonseca Cardoso
Department of Neurosurgery, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil
Author
-
Italo Nogarotto Cembraneli
Departament of Medicine, University Center of Mineiros, Mineiros, GO, Brazil
Author
-
Leonardo Taveira Lopes
Department of Radiology, Hospital of Neurology Santa Mônica, Goiânia, GO, Brazil
Author
Abstract
Von Hippel-Lindau syndrome (VHL) is an autosomal dominant hereditary disease characterized by a variety of benign/malignant tumors, mainly hemangioblastomas, renal, pancreatic, and hepatic alterations, as well as pheochromocytoma. The disease is associated with high morbidity and mortality and can affect multiple family members. Due to the potential for serious complications and psychosocial impacts, early diagnosis is crucial for monitoring tumor lesions, multidisciplinary treatment, and appropriate genetic counseling.